Verona Pharma plc Quarterly Nonoperating Income (Expense) in USD from Q1 2020 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Verona Pharma plc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q3 2024.
- Verona Pharma plc Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$2.05M, a 223% decline year-over-year.
- Verona Pharma plc Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $3.62M, a 72.9% decline year-over-year.
- Verona Pharma plc annual Nonoperating Income (Expense) for 2023 was $13.7M, a 87.3% increase from 2022.
- Verona Pharma plc annual Nonoperating Income (Expense) for 2022 was $7.3M, a 58.8% decline from 2021.
- Verona Pharma plc annual Nonoperating Income (Expense) for 2021 was $17.7M, a 91.1% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)